ClinicalTrials.Veeva

Menu

Use of Varenicline for 4-weeks Prior to Quitting

Q

Queen Mary University of London

Status and phase

Completed
Phase 3

Conditions

Tobacco Dependence
Smoking Cessation

Treatments

Drug: Varenicline
Drug: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT00789074
qmul120508

Details and patient eligibility

About

Varenicline (Champix) is a relatively new medicine that is effective in helping people to quit smoking. It is normally started 1-week before stopping smoking and used for up to 12-24 weeks. We are trying to find out if using varenicline for an extended time (4-weeks) before stopping smoking is better than the standard 1-week of use prior to stopping.

The study will recruit 100 smokers who want to stop. They will be randomly allocated to receive varenicline(4-weeks) or placebo (3-weeks followed by 1-week of active treatment as indicated by standard prescribing practice), followed by a 12-week open label treatment period where all participants will receive varenicline.

Enrollment

101 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Smokers seeking treatment
  • Aged 18 and over
  • Consenting to take part in the trial

Exclusion criteria

  • Pregnant or breastfeeding
  • End-stage renal disease
  • Used varenicline in the past 6 months
  • Unable to fill in questionnaires in English
  • Current psychiatric illness
  • Current serious illness including uncontrolled hypertension and recent cardiac event
  • Sensitivity to varenicline currently enrolled in other research projects.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

101 participants in 2 patient groups, including a placebo group

Varenicline pre-treatmemt
Experimental group
Description:
Participants will use varenicline (1mg BD) 4-weeks prior to quitting
Treatment:
Drug: Varenicline
Placebo
Placebo Comparator group
Description:
Participants will use 3 weeks of placebo, followed by 1 week of varenicline, prior to quitting
Treatment:
Drug: Placebo
Drug: Varenicline

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems